
Currently out of the existing stock ratings of Michael Huang, 15 are a BUY (100%).
Analyst Michael Huang, has had 100% of price targets met with an average potential upside of 38.18%, reached in 348 days on average. Previously, Michael Huang worked at NEEDHAM.
Michael Huang has documented 56 price targets and ratings displayed on 7 stocks. The coverage was on the Technology sector.
Most recent stock forecast was given on MDSO, Medidata Solutions at 22-Apr-2016.
Analyst best performing recommendations are on CRM (SALESFORCE.COM).
The best stock recommendation documented was for CRM (SALESFORCE.COM) on 2/22/2012. The price target of $34.75 was fulfilled within 2 days with a profit of $2.73 (8.53%), with a performance score of 42.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Nov-2024
$250
$59.6 (31.30%)
$300
2 days ago
(17-Nov-2026)
Hold Since 16-Oct-2025
$250
$59.6 (31.30%)
$225
30 days ago
(21-Oct-2026)
22/22 (100%)
$8.22 (3.40%)
70
Buy Since 03-Jun-2025
$300
$109.6 (57.56%)
$300
30 days ago
(21-Oct-2026)
5/17 (29.41%)
$58.22 (24.08%)
51
Sell Since 18-May-2026
$285
$94.6 (49.68%)
$160
1 months 8 days ago
(12-Oct-2026)
1/2 (50%)
$51.08 (21.84%)
30
Buy Since 01-Jun-2023
$315
$124.6 (65.44%)
$315
2 months 2 days ago
(18-Sep-2026)
44/67 (65.67%)
$77.08 (32.40%)
279